SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950103-18-003539
Filing Date
2018-03-20
Accepted
2018-03-20 14:52:24
Documents
2
Group Members
IDG-ACCEL CHINA GROWTH FUND GP III ASSOCIATES LTD.IDG-ACCEL CHINA GROWTH FUND III ASSOCIATES L.P.IDG-ACCEL CHINA GROWTH FUND III L.P.IDG-ACCEL CHINA III INVESTORS L.P.QUAN ZHOU

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A dp88343_sc13da.htm SC 13D/A 125505
2 EXHIBIT 99.3 dp88343_ex9903.htm EX-99.3 286309
  Complete submission text file 0000950103-18-003539.txt   413473
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 18701634
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address UNIT 1509, THE CENTER 99 QUEEN'S ROAD, CENTRAL HONG KONG F4 00000
Business Address
Ho Chi Sing (Filed by) CIK: 0001545806 (see all company filings)

Type: SC 13D/A